{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:15:38Z","timestamp":1793153738628,"version":"4.5.0"},"reference-count":167,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T00:00:00Z","timestamp":1580860800000},"content-version":"vor","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jacc.2018.10.075","type":"journal-article","created":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T17:00:48Z","timestamp":1548781248000},"page":"457-476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":259,"title":["Use of Medication for Cardiovascular\u00a0Disease\u00a0During Pregnancy"],"prefix":"10.1016","volume":"73","author":[{"given":"Dan G.","family":"Halpern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine R.","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Pinnelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpi","family":"Mehta-Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E.","family":"Economy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Marie","family":"Valente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2018.10.075_bib1","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/eurheartj\/ehy340","article-title":"2018 ESC guidelines for the management of cardiovascular diseases during pregnancy","volume":"39","author":"Regit-Azgrosek","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2018.10.075_bib2","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/AOG.0000000000002114","article-title":"Pregnancy-related mortality in the United States, 2011-2013","volume":"130","author":"Creanga","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jacc.2018.10.075_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/0884217504262970","article-title":"Hypertensive disorders of pregnancy","volume":"33","author":"Peters","year":"2004","journal-title":"J\u00a0Obstet Gynecol Neonatal Nurs"},{"key":"10.1016\/j.jacc.2018.10.075_bib4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1471-0528.2010.02743.x","article-title":"Chronic heart disease and severe obstetric morbidity among hospitalisations for pregnancy in the USA: 1995-2006","volume":"118","author":"Kuklina","year":"2011","journal-title":"BJOG"},{"key":"10.1016\/j.jacc.2018.10.075_bib5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijcard.2014.09.013","article-title":"Cardiac medication during pregnancy, data from the ROPAC","volume":"177","author":"Ruys","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2018.10.075_bib6","doi-asserted-by":"crossref","first-page":"e000712","DOI":"10.1161\/JAHA.113.000712","article-title":"Pregnancy complicated by valvular heart disease: an update","volume":"3","author":"Nanna","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2018.10.075_bib7","first-page":"1073","article-title":"Maternal hemodynamics and aortic diameter in normal and hypertensive pregnancies","volume":"78","author":"Easterling","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jacc.2018.10.075_bib8","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1161\/CIRCULATIONAHA.114.009029","article-title":"Cardiovascular physiology of pregnancy","volume":"130","author":"Sanghavi","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.10.075_bib9","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1471-0528.1987.tb02286.x","article-title":"Haemodynamic changes during the puerperium: a Doppler and M-mode echocardiographic study","volume":"94","author":"Robson","year":"1987","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jacc.2018.10.075_bib10","doi-asserted-by":"crossref","first-page":"e1002160","DOI":"10.1371\/journal.pmed.1002160","article-title":"Pregnancy-associated changes in pharmacokinetics: a systematic review","volume":"13","author":"Pariente","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.jacc.2018.10.075_bib11","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.1471-0528.1970.tb03423.x","article-title":"Transit time in the small intestine in pregnancy","volume":"77","author":"Parry","year":"1970","journal-title":"J\u00a0Obstet Gynaecol Br Commonw"},{"key":"10.1016\/j.jacc.2018.10.075_bib12","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2165\/00003088-199733050-00002","article-title":"Pharmacokinetic changes during pregnancy and their clinical relevance","volume":"33","author":"Loebstein","year":"1997","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.jacc.2018.10.075_bib13","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00007691-198104000-00003","article-title":"Effect of antacids on phenytoin bioavailability","volume":"3","author":"Carter","year":"1981","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jacc.2018.10.075_bib14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/BF00609896","article-title":"Pharmacokinetics of sotalol during pregnancy","volume":"24","author":"O'Hare","year":"1983","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2018.10.075_bib15","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/BF00556896","article-title":"Pharmacokinetics of propranolol during pregnancy","volume":"27","author":"O'Hare","year":"1984","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2018.10.075_bib16","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1517\/17425255.2.6.947","article-title":"Using pharmacokinetics to predict the effects of pregnancy and maternal-infant transfer of drugs during lactation","volume":"2","author":"Anderson","year":"2006","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.jacc.2018.10.075_bib17","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/sj.clpt.6100377","article-title":"Pharmacokinetic studies in pregnant women","volume":"83","author":"Anger","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jacc.2018.10.075_bib18","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.semperi.2015.08.003","article-title":"Pharmacokinetics of drugs in pregnancy","volume":"39","author":"Feghali","year":"2015","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.jacc.2018.10.075_bib19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fphar.2014.00065","article-title":"Physiologic and pharmacokinetic changes in pregnancy","volume":"5","author":"Costantine","year":"2014","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jacc.2018.10.075_bib20","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ajog.2004.08.030","article-title":"Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancy","volume":"192","author":"Tracy","year":"2005","journal-title":"Am J Obs Gyn"},{"key":"10.1016\/j.jacc.2018.10.075_bib21","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0009-9236(97)90118-1","article-title":"Induction of CYP2D6 in pregnancy","volume":"62","author":"Wadelius","year":"1997","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jacc.2018.10.075_bib22","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0002-9378(90)90386-L","article-title":"Labetalol pharmacokinetics in pregnancy-induced hypertension","volume":"162","author":"Rogers","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jacc.2018.10.075_bib23","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ki.1980.124","article-title":"Renal hemodynamics and tubular function normal human pregnancy","volume":"18","author":"Davison","year":"1980","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacc.2018.10.075_bib24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1471-0528.1981.tb00930.x","article-title":"Serial changes in 24 hour creatinine clearance during normal menstrual cycles and the first trimester of pregnancy","volume":"88","author":"Davison","year":"1981","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jacc.2018.10.075_bib25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1053\/j.ackd.2013.01.012","article-title":"Renal physiology of pregnancy","volume":"20","author":"Cheung","year":"2013","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.jacc.2018.10.075_bib26","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/00000542-196507000-00005","article-title":"Water and electrolyte balance during pregnancy","volume":"26","author":"Little","year":"1965","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jacc.2018.10.075_bib27","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.semnephrol.2004.07.008","article-title":"The renal response to preeclampsia","volume":"24","author":"Moran","year":"2004","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.jacc.2018.10.075_bib28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/0091270004269704","article-title":"Pharmacokinetics and pharmacodynamics of atenolol during pregnancy and postpartum","volume":"45","author":"Hebert","year":"2005","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jacc.2018.10.075_bib29","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/j.1875-9114.1998.tb03906.x","article-title":"Pharmacokinetic and pharmacodynamic evaluation of atenolol during and after pregnancy","volume":"18","author":"Hurst","year":"1998","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jacc.2018.10.075_bib30","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2174\/138161206776389813","article-title":"History and evolution of reproductive and developmental toxicology guidelines","volume":"12","author":"Collins","year":"2006","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jacc.2018.10.075_bib31","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1542-2011.2011.00062.x","article-title":"Governmental oversight of prescribing medications: history of the US Food and Drug Administration and prescriptive authority","volume":"56","author":"Plank","year":"2011","journal-title":"J\u00a0Midwifery Womens Health"},{"key":"10.1016\/j.jacc.2018.10.075_bib33","unstructured":"Federal Register. Part 201 (21 CFR part 201) (44\u00a0FR 37434, June 26, 1979). Available at: https:\/\/www.govinfo.gov\/content\/pkg\/FR-2014-12-04\/pdf\/2014-28241.pdf. Accessed December 29, 2018."},{"key":"10.1016\/j.jacc.2018.10.075_bib34","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/jmwh.12611","article-title":"The 2015 US Food and Drug Administration Pregnancy and Lactation Labeling Rule","volume":"62","author":"Brucker","year":"2017","journal-title":"J\u00a0Midwifery Womens Health"},{"key":"10.1016\/j.jacc.2018.10.075_bib35","first-page":"1","article-title":"Update on overall prevalence of major birth defects--Atlanta, Georgia, 1978-2005","volume":"57","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jacc.2018.10.075_bib36","unstructured":"American College of Obstetricians and Gynecologists. Frequently Asked Questions: Miscarriage and Molar Pregnancy, August 2015. Available at: https:\/\/www.acog.org\/-\/media\/For-Patients\/faq090.pdf. Accessed March 6, 2018."},{"key":"10.1016\/j.jacc.2018.10.075_bib37","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJM199804163381607","article-title":"Drugs in pregnancy","volume":"338","author":"Koren","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2018.10.075_bib38","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1161\/CIR.0000000000000300","article-title":"Cardiac arrest in pregnancy: a scientific statement from the American Heart Association","volume":"132","author":"Jeejeebhoy","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.10.075_bib39","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/CIRCEP.114.001517","article-title":"Contemporary management of arrhythmias during pregnancy","volume":"7","author":"Enriquez","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2018.10.075_bib40","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/clc.20326","article-title":"Frequency and outcome of arrhythmias complicating admission during pregnancy: experience from a high-volume and ethnically-diverse obstetric service","volume":"31","author":"Li","year":"2008","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2018.10.075_bib41","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/europace\/eur018","article-title":"Cardiac outcome of pregnancy in women with a pacemaker and women with untreated atrioventricular conduction block","volume":"13","author":"Thaman","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2018.10.075_bib42","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1161\/01.CIR.96.9.2808","article-title":"Implantable cardioverter-defibrillators and pregnancy: a safe combination?","volume":"96","author":"Natale","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.10.075_bib43","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0002-9149(99)80195-7","article-title":"Effects of pregnancy on first onset and symptoms of paroxysmal supraventricular tachycardia","volume":"76","author":"Lee","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2018.10.075_bib44","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0002-9149(99)80597-9","article-title":"Adenosine therapy for supraventricular tachycardia during pregnancy","volume":"75","author":"Elkayam","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2018.10.075_bib45","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S1701-2163(16)34980-5","article-title":"Adenosine for maternal supraventricular tachycardia and preterm delivery","volume":"33","author":"Matsubara","year":"2011","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jacc.2018.10.075_bib46","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/jamainternmed.2017.0608","article-title":"Beta-blocker exposure in pregnancy and risk of fetal cardiac anomalies","volume":"177","author":"Duan","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2018.10.075_bib47","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s40264-017-0627-x","article-title":"Beta-blocker use in pregnancy and risk of specific congenital anomalies: a European case-malformed control study","volume":"41","author":"Bergman","year":"2018","journal-title":"Drug Saf"},{"key":"10.1016\/j.jacc.2018.10.075_bib48","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1161\/HYPERTENSIONAHA.111.00833","article-title":"The risk of congenital malformations associated with exposure to beta-blockers early in pregnancy: a meta-analysis","volume":"62","author":"Yakoob","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2018.10.075_bib49","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/AOG.0000000000000103","article-title":"Maternal hypertension, medication use, and hypospadias in the National Birth Defects Prevention Study","volume":"123 Pt 1","author":"Van Zutphen","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jacc.2018.10.075_bib50","doi-asserted-by":"crossref","first-page":"e20160731","DOI":"10.1542\/peds.2016-0731","article-title":"Late pregnancy beta blocker exposure and risks of neonatal hypoglycemia and bradycardia","volume":"138","author":"Bateman","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.jacc.2018.10.075_bib51","doi-asserted-by":"crossref","first-page":"e001185","DOI":"10.1136\/bmjopen-2012-001185","article-title":"beta-Blocker treatment during pregnancy and adverse pregnancy outcomes: a nationwide population-based cohort study","volume":"2","author":"Meidahl Petersen","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.jacc.2018.10.075_bib52","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/1471-0528.12522","article-title":"Treatment with oral beta-blockers during pregnancy complicated by maternal heart disease increases the risk of fetal growth restriction","volume":"121","author":"Ersb\u00f8ll","year":"2014","journal-title":"BJOG"},{"key":"10.1016\/j.jacc.2018.10.075_bib53","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0895-7061(99)00031-X","article-title":"Atenolol and fetal growth in pregnancies complicated by hypertension","volume":"12","author":"Lydakis","year":"1999","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacc.2018.10.075_bib54","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0002-9149(97)00163-X","article-title":"Effect of atenolol on birth weight","volume":"79","author":"Lip","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2018.10.075_bib55","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0890-6238(97)00021-X","article-title":"Antenatal exposure to atenolol and retroperitoneal fibromatosis","volume":"11","author":"Satg\u00e9","year":"1997","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.jacc.2018.10.075_bib56","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0002-9378(79)90436-8","article-title":"Long-term propranolol therapy in pregnancy: maternal and fetal outcome","volume":"135","author":"Pruyn","year":"1979","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jacc.2018.10.075_bib57","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/jcph.631","article-title":"Pharmacokinetics of metoprolol during pregnancy and lactation","volume":"56","author":"Ryu","year":"2016","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jacc.2018.10.075_bib58","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF00271365","article-title":"Plasma concentration\u2014effect relationship of metoprolol during and after pregnancy","volume":"44","author":"H\u00f6gstedt","year":"1993","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2018.10.075_bib59","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/pds.2068","article-title":"Risks of congenital malformations and perinatal events among infants exposed to calcium channel and beta-blockers during pregnancy","volume":"20","author":"Davis","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jacc.2018.10.075_bib60","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/AOG.0000000000000908","article-title":"Calcium channel blocker exposure in late pregnancy and the risk of neonatal seizures","volume":"126","author":"Bateman","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jacc.2018.10.075_bib61","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.reprotox.2008.05.065","article-title":"The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study","volume":"26","author":"Weber-Schoendorfer","year":"2008","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.jacc.2018.10.075_bib62","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/jmf.14.2.132.135","article-title":"Verapamil-sensitive idiopathic left ventricular tachycardia in pregnancy","volume":"14","author":"Cleary-Goldman","year":"2003","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jacc.2018.10.075_bib63","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0196-0644(05)81615-4","article-title":"Verapamil in the treatment of maternal paroxysmal supraventricular tachycardia","volume":"20","author":"Byerly","year":"1991","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jacc.2018.10.075_bib64","first-page":"16S","article-title":"Supraventricular tachycardia in pregnancy: cardioversion with verapamil","volume":"63 Suppl","author":"Klein","year":"1984","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jacc.2018.10.075_bib65","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2165\/00003088-198712040-00002","article-title":"The pharmacokinetics of antiarrhythmic agents in pregnancy and lactation","volume":"12","author":"Mitani","year":"1987","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jacc.2018.10.075_bib66","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2165\/00003495-198325020-00002","article-title":"Calcium antagonists","volume":"25","author":"Kates","year":"1983","journal-title":"Drugs"},{"key":"10.1016\/j.jacc.2018.10.075_bib67","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/pd.1970151121","article-title":"Congenital hypertrophic cardiomyopathy associated with in utero verapamil exposure","volume":"15","author":"Shen","year":"1995","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jacc.2018.10.075_bib68","first-page":"217","article-title":"Diltiazem for maintenance tocolysis of preterm labor: comparison to nifedipine in a randomized trial","volume":"7","author":"El-Sayed","year":"1998","journal-title":"J\u00a0Matern Fetal Med"},{"key":"10.1016\/j.jacc.2018.10.075_bib69","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1080\/jmf.12.6.408.412","article-title":"Role of diltiazem in pregnant women with chronic renal disease","volume":"12","author":"Khandelwal","year":"2002","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jacc.2018.10.075_bib70","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2165\/00003495-198529050-00001","article-title":"Diltiazem","volume":"29","author":"Chaffman","year":"1985","journal-title":"Drugs"},{"key":"10.1016\/j.jacc.2018.10.075_bib71","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJM198504113121516","article-title":"Excretion of diltiazem in human milk","volume":"312","author":"Okada","year":"1985","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2018.10.075_bib72","first-page":"23","article-title":"Digoxin: placental transfer, effects on the fetus, and therapeutic use in the newborn","volume":"2","author":"Soyka","year":"1975","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.jacc.2018.10.075_bib73","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2165\/00044011-199509040-00003","article-title":"Clearance prediction and drug dosage in pregnancy","volume":"9","author":"Gonser","year":"1995","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.jacc.2018.10.075_bib74","first-page":"248","article-title":"Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study","volume":"84","author":"Hebert","year":"2008","journal-title":"Clin Pharmacol"},{"key":"10.1016\/j.jacc.2018.10.075_bib75","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1210\/jcem-58-4-748","article-title":"Endogenous digoxin-immunoreactive substance in human pregnancies","volume":"58","author":"Graves","year":"1984","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2018.10.075_bib76","doi-asserted-by":"crossref","first-page":"e272","DOI":"10.1055\/s-0036-1586241","article-title":"Digoxin therapy of fetal superior ventricular tachycardia: are digoxin serum levels reliable?","volume":"6","author":"Saad","year":"2016","journal-title":"AJP Rep"},{"key":"10.1016\/j.jacc.2018.10.075_bib77","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJM197211162872003","article-title":"Serum digoxin concentrations in the human fetus, neonate and infant","volume":"287","author":"Rogers","year":"1972","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2018.10.075_bib78","first-page":"691","article-title":"Arrhythmogenic right ventricular dysplasia: pregnancy under flecainide treatment","volume":"28","author":"Villanova","year":"1998","journal-title":"G\u00a0Ital Cardiol"},{"key":"10.1016\/j.jacc.2018.10.075_bib79","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/hrt.72.3.297","article-title":"Successful use of flecainide to treat new onset maternal ventricular tachycardia in pregnancy","volume":"72","author":"Connaughton","year":"1994","journal-title":"Br Heart J"},{"key":"10.1016\/j.jacc.2018.10.075_bib80","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1046\/j.0960-7692.2001.00562.x","article-title":"Flecainide in the intrauterine treatment of fetal supraventricular tachycardia","volume":"19","author":"Krapp","year":"2002","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jacc.2018.10.075_bib81","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s002460010279","article-title":"Second-line treatment of fetal supraventricular tachycardia using flecainide acetate","volume":"22","author":"Ebenroth","year":"2001","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jacc.2018.10.075_bib82","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/bmj.296.6617.249","article-title":"Maternal administration of flecainide to terminate and suppress fetal tachycardia","volume":"296","author":"Wren","year":"1988","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.jacc.2018.10.075_bib83","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/0002-9378(91)90298-6","article-title":"Treatment of fetal supraventricular tachycardia with flecainide acetate after digoxin failure","volume":"165","author":"Kofinas","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jacc.2018.10.075_bib84","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.hrthm.2016.03.023","article-title":"Flecainide versus digoxin for fetal supraventricular tachycardia: comparison of two drug treatment protocols","volume":"13","author":"Sridharan","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2018.10.075_bib85","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.hrthm.2016.01.029","article-title":"High-dose flecainide is the most effective treatment of fetal supraventricular tachycardia","volume":"13","author":"Strizek","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2018.10.075_bib86","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2165\/00002018-199512010-00005","article-title":"Propafenone in the treatment of cardiac arrhythmias. A risk-benefit appraisal","volume":"12","author":"Capucci","year":"1995","journal-title":"Drug Saf"},{"key":"10.1016\/j.jacc.2018.10.075_bib87","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2125.1991.tb03945.x","article-title":"Transfer of propafenone and 5-OH-propafenone to foetal plasma and maternal milk","volume":"32","author":"Libardoni","year":"1991","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2018.10.075_bib88","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/BF01856555","article-title":"Propafenone in Wolff-Parkinson-White syndrome at risk","volume":"4","author":"Santinelli","year":"1990","journal-title":"Cardiovasc Drug Ther"},{"key":"10.1016\/j.jacc.2018.10.075_bib89","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2125.1988.tb03413.x","article-title":"Propafenone in the treatment of chronic ventricular arrhythmias in a pregnant patient","volume":"26","author":"Brunozzi","year":"1988","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2018.10.075_bib90","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00000542-198908000-00024","article-title":"Continuous epidural lidocaine infusion in the parturient with paroxysmal ventricular tachycardia","volume":"71","author":"Juneja","year":"1989","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jacc.2018.10.075_bib91","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1177\/000331978403500812","article-title":"Paroxysmal ventricular tachycardia associated with Bell's palsy in a teenager at late pregnancy","volume":"35","author":"Menon","year":"1984","journal-title":"Angiology"},{"key":"10.1016\/j.jacc.2018.10.075_bib92","first-page":"33","article-title":"Mexilitene use in pregnancy","volume":"8","author":"Gregg","year":"1988","journal-title":"J Perinatol"},{"key":"10.1016\/j.jacc.2018.10.075_bib93","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1111\/j.1540-8159.2010.02740.x","article-title":"Electrical storm in Brugada syndrome during pregnancy","volume":"34","author":"Sharif-Kazemi","year":"2011","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2018.10.075_bib94","first-page":"58","article-title":"Procainamide administration during pregnancy","volume":"12","author":"Allen","year":"1993","journal-title":"Clin Pharm"},{"key":"10.1016\/j.jacc.2018.10.075_bib95","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2165\/00003088-198409020-00002","article-title":"Clinical pharmacokinetics of amiodarone","volume":"9","author":"Latini","year":"1984","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jacc.2018.10.075_bib96","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.jp.7211104","article-title":"Amiodarone-induced neonatal hypothyroidism: a unique form of transient early-onset hypothyroidism","volume":"24","author":"Lomenick","year":"2004","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.jacc.2018.10.075_bib97","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/BF03343825","article-title":"Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment","volume":"24","author":"Bartalena","year":"2001","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.jacc.2018.10.075_bib98","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.acvd.2008.08.012","article-title":"Fetal tachycardia: a role for amiodarone as first- or second-line therapy?","volume":"101","author":"P\u00e9zard","year":"2008","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.jacc.2018.10.075_bib99","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3233\/NPM-14814017","article-title":"Favorable neurodevelopmental outcome in a hypothyroid neonate following intracordal amiodarone for cardioversion of refractory supraventricular tachycardia in a fetus","volume":"7","author":"Capone","year":"2014","journal-title":"J\u00a0Neonatal Perinatal Med"},{"key":"10.1016\/j.jacc.2018.10.075_bib100","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/BF03350801","article-title":"Transient neonatal hypothyroidism after gestational exposure to amiodarone: a follow-up of two cases","volume":"21","author":"Grosso","year":"1998","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.jacc.2018.10.075_bib101","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.biopha.2010.01.020","article-title":"Developmental delay associated with normal thyroidal function and long-term amiodarone therapy during fetal and neonatal life","volume":"64","author":"Mikovic","year":"2010","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jacc.2018.10.075_bib102","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/pd.1970120903","article-title":"Amiodarone treatment in pregnancy for dilatative cardiomyopathy with ventricular malignant extrasystole and normal maternal and neonatal outcome","volume":"12","author":"Valensise","year":"1992","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jacc.2018.10.075_bib103","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/ehj\/9.1.106","article-title":"Amiodarone during pregnancy","volume":"9","author":"Strunge","year":"1988","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2018.10.075_bib104","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1161\/01.CIR.101.23.2721","article-title":"Sotalol in the treatment of fetal dysrhythmias","volume":"101","author":"Oudijk","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.10.075_bib105","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/ncpneph0623","article-title":"Hypertension in pregnancy: an emerging risk factor for cardiovascular disease","volume":"3","author":"Garovic","year":"2007","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.jacc.2018.10.075_bib106","first-page":"1122","article-title":"Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy","volume":"122","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jacc.2018.10.075_bib107","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/GRF.0000000000000247","article-title":"Pitfalls with the New American College of Obstetricians and Gynecologists Task Force on Hypertension in Pregnancy","volume":"60","author":"Pauli","year":"2017","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.jacc.2018.10.075_bib108","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1161\/CIRCULATIONAHA.113.003904","article-title":"Chronic hypertension in pregnancy","volume":"129","author":"Seely","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.10.075_bib109","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1056\/NEJMoa1404595","article-title":"Less-tight versus tight control of hypertension in pregnancy","volume":"372","author":"Magee","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2018.10.075_bib110","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1080\/14740338.2016.1237500","article-title":"Treatment options for hypertension in pregnancy and puerperium","volume":"15","author":"Amro","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jacc.2018.10.075_bib111","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2165\/00128072-200002060-00002","article-title":"Effects of antihypertensive drugs on the unborn child: what is known, and how should this influence prescribing?","volume":"2","author":"Khedun","year":"2000","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.jacc.2018.10.075_bib112","first-page":"CD002252","article-title":"Antihypertensive drug therapy for mild to moderate hypertension during pregnancy","volume":"2","author":"Abalos","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2018.10.075_bib113","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s40262-013-0123-0","article-title":"Influence of gestational age and body weight on the pharmacokinetics of labetalol in pregnancy","volume":"53","author":"Fischer","year":"2014","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jacc.2018.10.075_bib114","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1053\/j.semperi.2015.08.011","article-title":"A\u00a0review of oral labetalol and nifedipine in mild to moderate hypertension in pregnancy","volume":"39","author":"Clark","year":"2015","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.jacc.2018.10.075_bib115","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1471-2393-14-93","article-title":"Nifedipine versus atosiban in the treatment of threatened preterm labour (Assessment of Perinatal Outcome after Specific Tocolysis in Early Labour: APOSTEL III-Trial)","volume":"14","author":"van Vliet","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.jacc.2018.10.075_bib116","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1111\/1471-0528.12428","article-title":"Outpatient calcium\u2013channel blockers and the risk of postpartum haemorrhage: a cohort study","volume":"120","author":"Bateman","year":"2013","journal-title":"BJOG"},{"key":"10.1016\/j.jacc.2018.10.075_bib117","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0140-6736(82)92202-4","article-title":"Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children","volume":"1","author":"Cockburn","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2018.10.075_bib118","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1365-2710.2009.01078.x","article-title":"Hepatotoxicity of alpha-methyldopa in pregnancy","volume":"5","author":"Slim","year":"2010","journal-title":"J\u00a0Clin Pharm Ther"},{"key":"10.1016\/j.jacc.2018.10.075_bib119","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1161\/CIR.0000000000000458","article-title":"Management of pregnancy in patients with complex congenital heart disease: a scientific statement for healthcare professionals from the American Heart Association","volume":"135","author":"Canobbio","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.10.075_bib120","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/00016349509024401","article-title":"Effects of hydralazine on placental and renal circulation in pre-eclampsia","volume":"74","author":"Gudmundsson","year":"1995","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jacc.2018.10.075_bib121","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/bmj.327.7421.955","article-title":"Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis","volume":"327","author":"Magee","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2018.10.075_bib122","first-page":"634","article-title":"Clonidine hydrochloride--a safe and effective antihypertensive agent in pregnancy","volume":"66","author":"Horvath","year":"1985","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jacc.2018.10.075_bib123","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1124\/dmd.108.024984","article-title":"Clonidine pharmacokinetics in pregnancy","volume":"37","author":"Buchanan","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jacc.2018.10.075_bib124","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/bmj.290.6461.17","article-title":"Overview of randomised trials of diuretics in pregnancy","volume":"290","author":"Collins","year":"1985","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.jacc.2018.10.075_bib125","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2125.2001.01310.x","article-title":"Effect of diuretics on fetal growth: a drug effect or confounding by indication? Pooled Danish and Scottish cohort data","volume":"51","author":"Olesen","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2018.10.075_bib126","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ajog.2007.09.009","article-title":"Increasing exposure to angiotensin-converting enzyme inhibitors in pregnancy","volume":"198","author":"Bowen","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jacc.2018.10.075_bib127","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","volume":"70","author":"Yancy","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2018.10.075_bib128","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1253\/circj.CJ-15-0617","article-title":"Beta-blockers and fetal growth restriction in pregnant women with cardiovascular disease","volume":"80","author":"Tanaka","year":"2016","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2018.10.075_bib129","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/ejhf.586","article-title":"Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy","volume":"18","author":"Bauersachs","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2018.10.075_bib130","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/0002-9378(74)90689-9","article-title":"The action of vasopressors on isolated uterine arteries","volume":"118","author":"Van Nimwegen","year":"1974","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jacc.2018.10.075_bib131","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1093\/eurheartj\/ehx355","article-title":"Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study","volume":"38","author":"Hilfiker-Kleiner","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2018.10.075_bib132","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1053\/j.semperi.2014.04.022","article-title":"Management of pregnancy in the post-cardiac transplant patient","volume":"38","author":"Abdalla","year":"2014","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.jacc.2018.10.075_bib133","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1161\/CIRCULATIONAHA.113.002054","article-title":"Pregnancy-associated acute myocardial infarction: a review of contemporary experience in 150 cases between 2006 and 2011","volume":"129","author":"Elkayam","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.10.075_bib134","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12471-015-0677-6","article-title":"Ischaemic heart disease during pregnancy or post-partum: systematic review and case series","volume":"23","author":"Lameijer","year":"2015","journal-title":"Neth Heart J"},{"key":"10.1016\/j.jacc.2018.10.075_bib135","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/01.AOG.0000151998.50852.31","article-title":"Acute myocardial infarction in pregnancy and the puerperium: a population-based study","volume":"105","author":"Ladner","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jacc.2018.10.075_bib136","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/1471-0528.12066","article-title":"Pregnancy outcome following maternal exposure to statins: a multicentre prospective study","volume":"120","author":"Winterfeld","year":"2013","journal-title":"BJOG"},{"key":"10.1016\/j.jacc.2018.10.075_bib137","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jacl.2016.07.002","article-title":"The risks of statin use in pregnancy: A systematic review","volume":"10","author":"Karalis","year":"2016","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.jacc.2018.10.075_bib138","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJM200404083501524","article-title":"Central nervous system and limb anomalies in case reports of first-trimester statin exposure","volume":"350","author":"Edison","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2018.10.075_bib139","doi-asserted-by":"crossref","first-page":"h1035","DOI":"10.1136\/bmj.h1035","article-title":"Statins and congenital malformations: cohort study","volume":"350","author":"Bateman","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2018.10.075_bib140","article-title":"National Lipid Association recommendations for patient-centered management of dyslipidemia: part 2","volume":"9 Suppl","author":"Jacobson","year":"2015","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.jacc.2018.10.075_bib141","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/0897190014530425","article-title":"Pregnancy-related venous thromboembolism","volume":"27","author":"Armstrong","year":"2014","journal-title":"J\u00a0Pharm Pract"},{"key":"10.1016\/j.jacc.2018.10.075_bib142","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11239-015-1309-0","article-title":"Guidance for the treatment and prevention of obstetric-associated venous thromboembolism","volume":"41","author":"Bates","year":"2016","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jacc.2018.10.075_bib143","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/j.jacc.2014.02.536","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Nishimura","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2018.10.075_bib144","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0735-1097(99)00044-3","article-title":"Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves","volume":"33","author":"Vitale","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2018.10.075_bib145","first-page":"221","article-title":"A\u00a0case of congenital warfarin syndrome due to maternal drug administration during the pregnancy","volume":"22","author":"Dilli","year":"2011","journal-title":"Genet Couns"},{"key":"10.1016\/j.jacc.2018.10.075_bib146","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.1980.03300410037022","article-title":"Hazards of oral anticoagulants during pregnancy","volume":"243","author":"Stevenson","year":"1980","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2018.10.075_bib147","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.12.2011.5291","article-title":"Di Sala syndrome","volume":"2012","author":"Kumar","year":"2012","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jacc.2018.10.075_bib148","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.jacc.2011.12.018","article-title":"The search for a safe and effective anticoagulation regimen in pregnant women with mechanical prosthetic heart valves","volume":"59","author":"Elkayam","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2018.10.075_bib149","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1161\/CIRCULATIONAHA.115.015242","article-title":"Pregnancy in women with a mechanical heart valve: data of the European Society of Cardiology Registry of Pregnancy and Cardiac Disease (ROPAC)","volume":"132","author":"van Hagen","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.10.075_bib150","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1016\/j.jacc.2017.03.605","article-title":"Maternal and fetal outcomes of anticoagulation in pregnant women with mechanical heart valves","volume":"69","author":"Steinberg","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2018.10.075_bib151","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1111\/j.1538-7836.2010.03926.x","article-title":"Fondaparinux as an alternative anticoagulant therapy during pregnancy","volume":"8","author":"Knol","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jacc.2018.10.075_bib152","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2018.10.075_bib153","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(94)92633-6","article-title":"CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2018.10.075_bib154","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/CIRCULATIONAHA.114.003902","article-title":"Cardiovascular management in pregnancy: antithrombotic agents and antiplatelet agents","volume":"132","author":"Yarrington","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.10.075_bib155","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.2169\/internalmedicine.50.5294","article-title":"Clopidogrel treatment during pregnancy: a case report and a review of literature","volume":"50","author":"De Santis","year":"2011","journal-title":"Intern Med"},{"key":"10.1016\/j.jacc.2018.10.075_bib156","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s11239-012-0830-7","article-title":"Successful pregnancy and delivery on prasugrel treatment: considerations for the use of dual antiplatelet therapy during pregnancy in clinical practice","volume":"36","author":"Tello-Montoliu","year":"2013","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jacc.2018.10.075_bib157","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.bpobgyn.2014.03.003","article-title":"Pregnancy and pulmonary hypertension","volume":"28","author":"Pieper","year":"2014","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.jacc.2018.10.075_bib158","doi-asserted-by":"crossref","first-page":"709407","DOI":"10.1155\/2012\/709407","article-title":"Pulmonary hypertension in pregnancy: critical care management","volume":"2012","author":"Bassily-Marcus","year":"2012","journal-title":"Pulm Med"},{"key":"10.1016\/j.jacc.2018.10.075_bib159","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/ejhf.594","article-title":"Pulmonary hypertension and pregnancy outcomes: data from the Registry Of Pregnancy and Cardiac Disease (ROPAC) of the European Society of Cardiology","volume":"18","author":"Sliwa","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2018.10.075_bib160","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1086\/682230","article-title":"Statement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research Institute","volume":"5","author":"Hemnes","year":"2015","journal-title":"Pulm Circ"},{"key":"10.1016\/j.jacc.2018.10.075_bib161","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ijcard.2014.08.059","article-title":"Pregnancy among women with pulmonary arterial hypertension: a changing landscape?","volume":"177","author":"Tabarsi","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2018.10.075_bib162","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1183\/09031936.05.00128504","article-title":"The use of iloprost in early pregnancy in patients with pulmonary arterial hypertension","volume":"26","author":"Elliot","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacc.2018.10.075_bib163","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1002\/phar.1793","article-title":"Inhaled iloprost for chronic thromboembolic pulmonary hypertension (CTEPH) during pregnancy: a case report","volume":"36","author":"Horng","year":"2016","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jacc.2018.10.075_bib164","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1471-0528.2012.03295.x","article-title":"Pulmonary hypertension and pregnancy--a review of 12 pregnancies in nine women","volume":"119","author":"Curry","year":"2012","journal-title":"BJOG"},{"key":"10.1016\/j.jacc.2018.10.075_bib165","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000287638","article-title":"Favorable outcome of pregnancy with an elective use of epoprostenol and sildenafil in women with severe pulmonary hypertension","volume":"115","author":"Goland","year":"2010","journal-title":"Cardiology"},{"key":"10.1016\/j.jacc.2018.10.075_bib166","doi-asserted-by":"crossref","first-page":"117","DOI":"10.7326\/0003-4819-123-2-199507150-00007","article-title":"Cardiovascular problems in pregnant women with the Marfan syndrome","volume":"123","author":"Elkayam","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2018.10.075_bib167","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0015-0282(03)00974-9","article-title":"Risk of death in pregnancy achieved through oocyte donation in patients with Turner syndrome: a national survey","volume":"80","author":"Karnis","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jacc.2018.10.075_bib168","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0003-4975(03)00169-3","article-title":"Aortic dissection in pregnancy: analysis of risk factors and outcome","volume":"76","author":"Immer","year":"2003","journal-title":"Ann Thorac Surg"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109718393227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109718393227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:19:20Z","timestamp":1760015960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109718393227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":167,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0735109718393227"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2018.10.075","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Medication for Cardiovascular\u00a0Disease\u00a0During Pregnancy","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2018.10.075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}